Transcriptional silencing of tumor suppressor genes in association with DNA methylation contributes to malignant transformation. However, the specific DNA methyltransferases that initiate this process are unknown. Here we show that a de novo DNA methyltransferase, DNMT3b, substantially contributes to the oncogenic phenotype in a lung cancer model. Normal human bronchial epithelial (NHBE) cells expressing telomerase, SV40 large T antigen, and activated Ras were immortal, formed colonies in soft agar, and expressed DNMT3b. Antisense suppression of DNMT3b prevented soft agar growth. Furthermore, mouse embryo fibroblasts expressing T antigen and Ras formed soft agar colonies and large tumors, but fibroblasts from Dnmt3b À/À mice did not grow in soft agar and were much less tumorigenic in vivo. The tumor suppressor genes, FHIT, TSLC1, and RASSF1A were downregulated in transformed NHBE cells, and antisense DNMT3b treatment resulted in reexpression of FHIT and TSLC1. While expression of TSCL1 correlated with methylation of CpG dinucleotides in its promoter region, the expression of FHIT did not, suggesting that DNMT3b may silence genes by several mechanisms including direct DNA methylation or recruitment of proteins that modify chromatin. Regardless of mechanism, our data indicate that DNMT3b plays an important role in transformation.
Introduction
An essential step in cancer progression is abrogation of the growth controlling effects of tumor suppressor genes. This can occur by genetic means such as deletion of all or part of the tumor suppressor gene locus, or by the appearance of inactivating point mutations. However, another common mechanism of tumor suppressor inactivation is epigenetic transcriptional silencing in association with methylation of cytosines at CpG dinucleotides (Laird and Jaenisch, 1996; Chan et al., 2000) . Initially described for INK4A, hypermethylation has also been documented at silenced alleles of APC, BRCA1, Rb, and VHL (Sakai et al., 1991; Ohtani-Fujita et al., 1993; Gnarra et al., 1994; Greger et al., 1994; Herman et al., 1994 Herman et al., , 1995 Merlo et al., 1995) . Although debate continues about whether methylation is a cause or a consequence of transcriptional silencing, methyl CpG binding proteins and proteins with methyl CpG binding domains have been identified that have transcriptional repressor activity and are complexed with histone deacetylases (Jones et al., 1998; Nan et al., 1998; Cameron et al., 1999; Ng et al., 1999; Wade et al., 1999) . Thus, an appealing model would make DNA methylation a primary event that recruits proteins capable of repressing transcription both directly and via chromatin remodeling. However, the mechanisms responsible for initiating methylation of tumor suppressor genes are obscure.
Cytosine methylation is accomplished by DNA methyltransferases (DNMTs), and five mammalian DNMTs (DNMT1, DNMT2, DNMT3a, DNMT3b, and DNMT3L) have been characterized in detail. Most have a C-terminal catalytic domain containing the 10 DNA methyltransferase signature sequence motifs found in procaryotes (Lauster et al., 1989; Posfai et al., 1989) , and an N-terminal domain involved in proteinprotein interactions. DNMT1 has a preference for hemimethylated DNA and is required for maintenance of methylation patterns in embryos and adult tissues (Bestor et al., 1988; Li et al., 1992) . DNMT2 has only the C-terminal domain and, despite the presence of all of the enzymatic signature motifs, it has no detectable methyltransferase activity (Okano et al., 1998b) . In contrast to DNMT1, DNMT3a and DNMT3b are capable of efficient de novo DNA methylation during normal development (Lyko et al., 1999; Okano et al., 1999) . In particular, DNMT3b specifically methylates centromeric satellite repeats and is haploinsufficient in ICF syndrome in which these repeats are hypomethylated (Hansen et al., 1999; Okano et al., 1999; Xu et al., 1999) . DNMT3a's function is obscure and has not been associated with disease. Finally, DNMT3L comprises only a C-terminal domain related to DNMT3a and DNMT3b, but has none of the methyltransferase signature motifs (Aapola et al., 2000) .
Some DNMTs are overexpressed in tumor cells and their presumed ability to methylate tumor suppressor loci has led to the suggestion that they are involved in malignant transformation (Belinsky et al., 1996; Robertson et al., 1999) . In particular, DNMT1 activity is associated with the transformed state (Wu et al., 1993; Bakin and Curran, 1999) , but its relation to tumor progression is unclear. On one hand, antisense DNMT1 treatment of tumor cell lines with methylated INK4A resulted in demethylation of the locus, re-expression of p16, and cessation of cell growth (Fournel et al., 1999) . On the other hand, homozygous deletion of DNMT1 in the diploid human colon cancer cell line HCT116 had no effect on the status of a methylated and silenced wildtype p16
INK4A allele (Rhee et al., 2000) . These results imply either that another DNMT is necessary for maintaining INK4A methylation or that prolonged inactivation of DNMT1 by genetic deletion induces compensatory activity. As a result of its de novo methyltransferase activity, DNMT3b is an attractive candidate for the other DNMT that contributes to tumor suppressor gene silencing. In support of this notion, antisense suppression of DNMT3b in tumor cell lines restored tumor suppressor gene expression (Beaulieu et al., 2002) as did deletion of DNMT3b in DNMT1-deficient HCT116 (Rhee et al., 2002) . Nonetheless, the precise contribution of DNMT3b to tumor progression and transformation is unknown.
The epigenetic basis of transcriptional silencing has important therapeutic implications because the underlying nucleotide sequence of hypermethylated tumor suppressor genes remains unchanged. In fact, pharmacological or antisense-induced demethylation in experimental systems results in re-expression of tumor suppressor genes and restoration of growth control Otterson et al., 1995; Fournel et al., 1999) . Thus, a thorough understanding of the mechanisms of regulated DNA methylation would reveal likely targets for antineoplastic agents that could inhibit these processes and reinstate tumor suppressor gene expression. Here, we show that the expression of DNMT3b is required for full expression of the transformed phenotype, indicating that it plays an important role in malignant transformation.
Results

Engineered transformation of normal human bronchial epithelial (NHBE) cells
In order to investigate DNMT function in a well-defined epithelial cell transformation system, and because of the clinical importance of lung cancer, we developed a transformation model using normal human bronchial epithelial (NHBE) cells. Based on an approach established by others, we sequentially introduced human telomerase (hT), SV40 large T antigen (LT), and activated Ras into NHBE cells (Hahn et al., 1999) . In some experiments, human papillomavirus E6 and E7 genes were substituted for LT (Morales et al., 1999) .
Expression of hT alone increased the number of population doublings (PD) NHBE cells could undergo prior to senescence, but did not immortalize them as defined by a capacity to proliferate beyond 100 PDs (Figure 1a) . However, addition of LT or E6/E7 to hT did produce immortalized cells. Expression of activated Ras in cells expressing hT alone produced immediate growth arrest (not shown), but addition of activated Ras to cells expressing hT plus LT or hT plus E6/E7 had no effect on immortalization. Functional expression of these genes is demonstrated in Figure 1b , which shows that cells expressing hT had longer telomeres, cells expressing LT or E6/E7 expressed high levels of p16 To determine if these cells had attributes associated with oncogenic transformation, we tested their ability to form colonies in soft agar. Only cells expressing hT, LT, and activated Ras formed colonies; substitution of E6/ E7 for LT did not induce this trait (Table 1) . Thus, consistent with other reports, soft agar colony formation requires expression of LT along with hT and Ras (Hahn et al., 1999; Morales et al., 1999) . To make sure that this outcome was not dependent on the order in which the transduced genes exerted their effects, another line of NHBE cells was developed in which hT was introduced after E6/E7 or LT. In fact, the capacity for soft agar colony growth was associated with LT expression regardless of whether hT is introduced before or after LT (Table 1) .
Expression of DNMTs in transformed bronchial epithelial cells
To assess the effects of transformation on DNMT expression, we determined levels of DNMT protein or mRNA expression after gene transduction. hT, E6/E7, LT, and Ras each had incremental effects on increasing the expression of DNMT1, the effect of LT being strongest (Figure 2a ). The effects of LT and Ras on DNMT1 expression, and DNMT1's role as a downstream effector of these transforming genes, have been described earlier by others (Vertino et al., 1994; MacLeod and Szyf, 1995; Rouleau et al., 1995; Slack et al., 1999) . However, DNMT1 expression did not correlate with soft agar growth; expression levels were the same in hT/LT/Ras-transduced cells that were immortal and formed soft agar colonies and in hT/E6/ E7/Ras-transduced cells that were also immortal but did not form colonies. Expression of DNMT3a mRNA did not vary among cell lines. In contrast, introduction of LT drastically altered the expression levels of various DNMT3b splice forms, shown schematically in Figure 2b . Levels of DNMT3b1 and DNMT3b2 decreased substantially while levels of DNMT3b3 increased slightly. This resulted in DNMT3b expression patterns similar to those seen in the SV40-transformed human lung cell line BEAS-2B and the non-small cell lung cancer cell line Calu-1. The equivalent levels of histone H4 expression among these cell lines indicated that alterations in DNMT3b expression were not the result of differences in proliferation rate (Lee et al., 1996) .
To test the activities of human DNMT3b1 and DNMT3b3, we expressed them in insect cells and assessed their ability to methylate hemimethylated and unmethylated DNA substrates. (The catalytic domains of DNMT3b1 and DNMT3b2 are identical, Okano et al., 1998a) . Like murine Dnmt3b1 (Okano et al., 1998a) , human DNMT3b1 was an active de novo methyltransferase and had equivalent activity on hemimethylated DNA (Figure 2c ). Although murine Dnmt3b3 produced in bacteria has been reported to be inactive (Aoki et al., 2001 ), eucaryotically produced DNMT3b3 was similar to DNMT3b1 in its ability to methylate both substrates. Thus, the predominant DNMT3b splice forms expressed in this model have comparable enzymatic activities, and the significance of alterations in their relative abundance is unclear. Nonetheless, it is notable that maximal changes in the ratio of DNMT3b1/2 to DNMT3b3 correlated with acquisition of anchorage independent growth.
DNMT3b is required for soft agar colony formation and tumor growth in vivo
To test whether DNMT3b is required for transformation and anchorage independence, overall DNMT3b expression was suppressed by antisense. An adenoviral vector containing several hundred base pairs of 5 0 DNMT3b antisense sequence efficiently infected hT/ LT/Ras-transduced NHBE cells ( Figure 3a ) and led to a time-and dose-dependent reduction in DNMT3b protein levels ( Figure 3b ). (Sense vectors did not produce an increase in DNMT3b because the inserted sequences were not full length.) Although infection with 200 MOI produced the most profound reduction in DNMT3b expression, both sense and antisense adenovirus at this dose caused nonspecific cytotoxicity. Since infection with antisense adenovirus at 100 MOI produced substantial reductions in DNMT3b expression without nonspecific toxicity, and because our experi- Cells were plated in soft agar at 3 Â 10 4 cells per well in six-well plates and colonies containing more than 100 cells were counted 3 weeks later. hT was introduced either before (Experiment 1) or after (Experiment 2) introduction of E6/E7 or LT. Only the combination of hT, LT, and Ras induced colony formation in soft agar regardless of the order of introduction of the genes. Adenovirus-transformed 293 cells and the non-small cell lung cancer cell line Calu-1 were used as positive controls DNMT3b and transformation K Soejima et al ments involved reinfection every 3-4 days, a dose of 100 MOI was chosen for all subsequent work.
Infection of hT/LT/Ras-transduced NHBE cells with the antisense DNMT3b virus had no effect on proliferation rate when cells were grown on tissue culture plastic ( Figure 4a ). However, the antisense DNMT3b virus reduced the number of soft agar colonies by 90% compared to the sense virus ( Figure 4b) . The rare, large colonies that appeared in the antisense DNMT3b treated population were not GFP-positive suggesting that the antisense virus was no longer present. The effects of antisense DNMT3b on hT/LT/Ras-transduced NHBE cells were also observed on Calu-1 cells (data not shown). To investigate the contributions of DNMT3a to the transformed phenotype, we suppressed its expression in hT/LT/Ras-transduced NHBE cells and in Calu-1 cells using a similar adenoviral approach. This maneuver had no effect on anchorage-dependent or anchorage-independent growth of either cell type (data not shown).
To confirm genetically that DNMT3b is required for anchorage-independent growth, we examined mouse embryonic fibroblasts (MEFs) derived from E12.5 Dnmt3b À/À or wild-type littermate embryos . LT and activated Ras were introduced into two independently derived cultures of wild-type and Dnmt3b À/À MEFs. (Telomerase was not introduced because of the substantial length of mouse telomeres.) As in human cells (Figure 2a) , LT induced expression of Dnmt1 in both the cell types, and the addition of activated Ras provided an incremental increase ( Figure 5 ). Dnmt3a expression was not affected. There were no differences in expression levels of Dnmt1 and Dnmt3a in cells from wild-type embryos compared to Dnmt3b À/À embryos indicating that the absence of Dnmt3b did not induce compensatory increases in the other Dnmts. Unlike NHBE cells examined in Figure 2 , wild-type MEFs predominantly express Dnmt3b3, and the levels of the splice variants were not affected by LT or Ras expression.
LT alone was sufficient to immortalize both wild-type and Dnmt3b
À/À MEFs and the addition of Ras had no effect on immortalization, although Ras alone caused abrupt apoptosis (data not shown). LT-and Ras-transduced Dnmt3b À/À MEFs grew at the same rate on tissue culture plastic as wild-type MEFs expressing the same oncogenes (Figure 6a ). Wild-type MEFs expressing LT alone formed only occasional (Figure 6b ). In contrast, LT-and Ras-transduced Dnmt3b À/À MEFs formed nearly 100-fold fewer colonies and the colonies that did appear were much smaller than those formed by wild-type MEFs. Similarly, LT-and Ras-transduced wild-type MEFs formed tumors in nude mice that appeared earlier and were larger at each time point than tumors formed by LT-and Ras-transduced Dnmt3b À/À MEFs (Figure 6c) . Furthermore, the growth of tumors formed by Dnmt3b À/À MEFs began to plateau by day 22, while tumors formed by wild-type MEFs continued to increase. Similar results were observed when MEFs were injected in syngeneic, immunocompetent mice (not shown).
Loss of DNMT3b is associated with re-expression of tumor suppressor genes
We next tested whether DNMT3b's activity in transformation was associated with suppression of tumor suppressor gene expression. Transformation of NHBE cells by hT, LT, and Ras significantly reduced the expression of FHIT, TSLC1, and RASSF1A as measured by semiquantitative RT-PCR (Ohta et al., 1996; Dammann et al., 2000; Kuramochi et al., 2001) (Figure 7 ). The expression of these genes was similarly reduced or absent in SK-LU-1 NSCLC cells. p16
INK4a
was not examined because inactivation of Rb by LT led to its overexpression as expected (Figure 1) (Shapiro et al., 1995) .
The dependence of tumor suppressor gene downregulation on DNMT3b was determined by infecting Antisense had no effect on the expression of RASSF1A, but it did restore the expression of FHIT and TSLC1 to levels approaching those of nontransformed NHBE cells (Figure 8a ). To determine whether loss of expression in transformed cells was associated with hypermethylation, we used bisulfitetreated genomic DNA as a template for PCR amplification and then sequenced 18-19 independently derived clones from each PCR reaction. Surprisingly, the degree of hypermethylation at these loci in transformed cells was low. For example, despite loss of FHIT expression in transformed cells, no methylated CpGs were detected at that locus. At the TSLC1 locus, only 18-28% of the CpGs known to undergo methylation in tumor cell lines were actually methylated in the hT/LT/Ras-transformed NHBE cells (Figure 8b ). Nonetheless, they were completely nonmethylated in cells infected with antisense DNMT3b adenovirus, suggesting a correlation between methylation status and gene expression. The effect of antisense DNMT3b treatment on methylation was significant by two measures. First, differences in the proportion of clones showing any methylation in DNA from sense-versus antisensetreated cells could be analysed in a 2 Â 2 table. Five of 19 clones from sense-treated cells showed methylation, while 0 of 18 clones from antisense-treated cells showed methylation. This difference was significant using Fisher's exact test (P ¼ 0.0463). Second, differences in methylation at each position between the two sets of clones were also shown to be significant using paired Student's t-test (P ¼ 0.0005). (As expected, the promoter region of INK4A was unmethylated in transformed NHBE cells.) À/À mice were infected with pBABE-puro alone (vector), pBABE-puro-LT alone (LT) or pBABE-puro-LT followed by pBABE-hygro-Ras (LT+Ras). A and B represent independently derived cell strains. The murine Dnmt3b splice forms correspond to the human DNMT3b splice forms shown in Figure 2b DNMT3b and transformation K Soejima et al
To rule out the presence of genome-wide hypermethylation in our transformation system, we examined global methylation patterns in these cells using a dCTP extension assay (Pogribny et al., 1999) . Increased incorporation of [ 3 H]dCTP into genomic DNA by DNA polymerase after digestion with methylation-sensitive restriction enzymes is a reflection of hypomethylation. Compared to parental NHBE cells, transformed NHBE cells were globally hypomethylated to the same extent as lung cancer cells (Figure 8c) . Thus, hypermethylation at TSLC1 occurred in a background of global hypomethylation, similar to authentic human tumors.
Discussion
Using a well-defined transformation system pioneered by others (Hahn et al., 1999; Morales et al., 1999) , we have found that DNMT3b expression is essential for a fully manifested neoplastic phenotype in lung epithelial cells and MEFs. Consistent with reports using other epithelial cell types, expression of hT, E6/E7, and activated Ras immortalized NHBE cells, but LT was required in order for cells to be anchorage independent. Acquisition of this trait correlated with alterations in expression of DNMT3b isoforms, and soft agar colony formation was abrogated by antisense suppression of DNMT3b. Furthermore, absence of Dnmt3b from MEFs expressing LT and/or Ras was associated with loss of soft agar colony growth and a marked reduction in the ability to form tumors in nude mice. The implications of altered expression levels among the DNMT3b isoforms are unclear because of limited information about their activities. We have shown that human DNMT3b1 and DNMT3b3 both have nearly equivalent de novo DNA methyltransferase activities. Thus, the regions missing from the catalytic domain of DNMT3b3 (Xie et al., 1999) are not required for enzymatic activity in vitro, and functional differences among the splice forms may involve specificities for associated proteins (discussed below). Hypothetically, for example, hypomethylation of pericentromeric satellite II DNA in association with hypermethylation of tumor suppressor genes might mean that DNMT3b1 is important for the former and DNMT3b3 for the latter. This might be the case even if DNMT3b3
were not enzymatically responsible for DNA methylation. The antisense sequences used in our studies are targeted against all DNMT3b isoforms and fibroblasts from Dnmt3b À/À embryos are missing all isoforms. Therefore, these results describe the effects of global alterations in DNMT3b expression and additional work will be required to understand the functions of specific isoforms in malignant transformation. Our findings on the importance of DNMT3b in transformation are consistent with reports that DNMT3b expression is elevated in several human cancers (Robertson et al., 1999) and that suppression of DNMT3b results in tumor cell apoptosis (Beaulieu et al., 2002) . However, it is not clear yet why DNMT3b is continually necessary for maintenance of Our results suggest either that a low level of ongoing de novo DNA methylation is required or that associated proteins are playing the essential role in DNMT3b-dependent transformation and DNA methylation is a surrogate for that activity.
Although it is tempting to speculate that DNMT3b is responsible for specific regional hypermethylation, there is no evidence that it directly methylates these loci. Other enzymes may perform this function in response to upstream effects wrought by DNMT3b, and patterns of locus methylation may differ among cell types suggesting that other factors may be involved. Furthermore, it
is not yet clear that DNMT3b's association with transformation depends on its enzymatic activity. In fact, our data indicate that tumor suppressor gene expression can be inhibited in the presence of DNMT3b without much locus methylation, in the case of TSLC1, or any, in the case of FHIT. This suggests that DNMT3b may contribute to gene silencing through the recruitment of chromatin remodeling enzymes rather than by direct methylation of target loci. For example, the N-terminal domain of DNMT3b, which is shared by all of the splice isoforms (Okano et al., 1998a) , has PWWP and plant homeodomain (PHD) motifs which may be involved in protein-protein interactions that influence transcriptional regulation or chromatin remodeling. For example, Dnmt3a is able to associate with histone deacetylase HDAC1 through its PHD domain, which by itself functions as a transcriptional repressor (Bachman et al., 2001; Fuks et al., 2001) . However, it remains to be demonstrated that DNMT3b can exert its influence on transformation by modulating HDAC activity.
At the same time, it should be noted that loss of DNMT3b could conceivably contribute to transformation in an indirect manner. Loss of DNA methyltransferases is associated with chromosomal instability and hypermutability (Chen et al., 1998; Hansen et al., 1999; Xu et al., 1999) , which are hallmarks of cancer susceptibility. In fact, this may be an explanation for the small amount of soft agar colony formation, and the delayed and attenuated tumor growth by LT-and Rastransduced Dnmt3b À/À MEFs ( Figure 6 ). During extended periods in culture or in vivo, hypermutability may have given rise to an occasional variant cell that attained some capacity for anchorage independence or tumor formation in vivo. While this may have been revealed by the selective pressures of our experimental systems, it is unlikely to be relevant in human cancers since patients with ICF syndrome do not have a cancer susceptibility phenotype.
Regardless of the precise mechanisms, our data indicate that DNMT3b contributes directly to transformation of both epithelial and mesenchymal cells. Disruption of enzymatic activity or protein-protein associations involving DNMT3b could provide novel cancer therapies. In particular, based on the model used in our work, these therapies could be effective in non-small cell lung cancer for which few active drugs exist.
Materials and methods
Cell lines
Phoenix producer cells were transfected with the following plasmids using FuGene6 (Roche Molecular Biochemicals, Indianapolis, IN, USA): pBABE-puro-hTERT and pBABEhygro-ras-V12 (gifts from RA Weinberg, Massachusetts Institute of Technology, Cambridge, MA, USA), and pBABE-puro-U19 and pLXSN-U19 (a gift from J DeCaprio, Dana-Farber Cancer Institute, Boston, MA, USA). U19 is an SV40 large T antigen variant lacking the SV40 origin DNA binding motif (Rios and Williams, 1990) . PA 317 cell lines producing pLXSN containing E6 and E7 were purchased from American Type Culture Collection (Manassas, VA, USA). Supernatants were used to infect NHBE cells (BioWhittaker, Walkersville, MD, USA), or mouse embryo fibroblasts (MEFs). MEFs were derived from E12.5 wild-type and Dnmt3b À/À embryos and provided as a generous gift by Dr En Li, Massachusetts General Hospital, Boston, MA, USA.
DNMT expression and enzyme assays cDNAs encoding DNMT3b1 and DNMT3b3 fused to calmodulin binding protein and the FLAG epitope were cloned into the pFastBac vector (Invitrogen, Carlsbad, CA, USA). Plasmids were used to transform DH10Bac cells (Invitrogen) in order to produce recombinant bacmids that were then used to transfect Sf21 insect cells. Viruses were amplified and used in a large-scale infection of Sf21 cells which were then lysed by sonication. A total of 50 mg of protein from clarified lysates was mixed with 1 mg of unmethylated or hemimethylated dsDNA substrates as described (Pradhan et al., 1998) , and 3 mCi S- [methyl- 3 H]adenosyl methionine (15 Ci/mmol, NEN, Boston MA, USA) in a total volume of 20 ml lysis buffer. The reaction was stopped, DNA was purified by phenol : CHCl 3 extraction and ethanol precipitation, and RNA was hydrolyzed. The mixture was spotted on Whatman DE-81 ion exchange filters, dried, and washed with sodium phosphate buffer (pH 7.0). Retained radioactivity was quantified by scintillation counting.
Adenoviruses cDNA fragments for DNMT3a (nucleotides À66-202 relative to ATG) and DNMT3b (nucleotides À107-149 relative to ATG) were generated by PCR, then cloned into a shuttle vector, pAdTrack-CMV. Plasmids were cotransformed into E. coli BJ5183 with an adenoviral backbone plasmid, pAdEasy-1. Recombinants were selected for kanamycin resistance, and linearized plasmid was transfected into 293 cells. Virus was harvested at 7 days post-transfection and used for experiments after amplification (He et al., 1998) .
Immunoblotting
A total of 100 mg protein from total cellular extracts was separated by SDS-PAGE and electrophoretically transferred to Immobilon-P (Millipore, Danvers, MA, USA). The following antibodies were used: LT and Ras, catalog numbers DP02 and OP40 from Oncogene Research Products (Boston, MA, USA); p53 and p16, clones DO-1 and N-20 (Santa Cruz Biotechnology); hDNMT1 and mDnmt1, generous gifts from Dr RA MacLeod (MethylGene Inc., Montreal, Canada) and Dr T Bestor (Columbia University, New York, NY, USA). Antiserum against mDnmt3b, a generous gift from Dr En Li (Massachusetts General Hospital, Boston, MA, USA) was DNMT3b and transformation K Soejima et al created by immunization of rabbits with an N-terminal peptide and was also used for detection of hDNMT3b.
Telomere length assay
Telomere length was measured by hybridizing a 32 P-labeled telomeric (CCCTAA) probe to HinfI-and RasI-digested genomic DNA as described (Hahn et al., 1999) . 0 . Primers for hDNMT3a and hDNMT3b (Robertson et al., 1999) , FHIT (Ohta et al., 1996) , and RASSF1A (Dammann et al., 2000) were reported elsewhere.
RT-PCR
Quantitative RT-PCR mRNA levels were quantified with real-time fluorescence detection using an ABI Prism 7700 Sequence Detection System (Perkin-Elmer Corp., Foster City, CA, USA) as described (Gibson et al., 1996) . Primer and probe sequences were: FHIT, ACCTAGACCTAAACGGCTCAGA, AAGGCTGCCGAA-TAAGGAG and 6FAM 5 0 -AGGCAGATTTGAGGTTT CCCCCTG-3 0 TAMRA; TSLC1, AACTGCACTGCTATG GCCA, GCCTTTTAGCTCTGTGTTCCC and 6FAM 5 0 -CCAGCCACGACTATCAGGTGGTTCAA-3 0 TAMRA; GAPDH, CCTCAAGATCATCAGCAATGC, CACGA-TACCAAAGTTGTCATG and 6FAM 5 0 -TCCTGCAC-CAACTGCTTAGCA-3 0 TAMRA.
Tumor growth in nude mice
Female nude mice (Cby.Cg-Foxn1 nu ) 6-8 weeks of age were injected with 5 Â 10 5 cells subcutaneously in the flank. Mice were housed together and measurements of tumor growth at the injection site were made.
Analysis of promoter methylation status
Bisulfite modification of genomic DNA was performed as reported (Herman et al., 1996) . Briefly, 1 mg of genomic DNA was denatured with NaOH (0.2 m final concentration), made 10 mm hydroquinone and 3 m sodium bisulfite, and incubated at 501C for 16 h. Modified DNA was purified using Wizard DNA purification resin (Promega, Madison, WI, USA) followed by ethanol precipitation. Methylation status was evaluated by direct sequencing of modified DNA samples after PCR amplification. PCR products were ligated into pGEM Easy (Promega) and 18 or more clones were sequenced to calculate average methylation levels. Primer sequences of PCR for FHIT and TSLC1 were reported elsewhere (Tanaka et al., 1998; Kuramochi et al., 2001) .
Radiolabeled [ 3 H]dCTP extension assay
We carried out single nucleotide extension reaction as described (Pogribny et al., 1999) with modifications. Briefly, 2 mg DNA was digested with HpaII and AciI. The extension assay was performed in a 25 ml reaction mixture containing 0.2 mg of digested DNA, 1 Â buffer II, 1.0 mm MgCl 2 , 0.25 U of AmpliTaq (Perkin-Elmer) with [ 3 H]dCTP and incubated at 561C for 1 h. Duplicate 10 ml aliquots from each reaction were applied on Whatman DE-81 ion exchange filters and washed three times with sodium phosphate buffer (pH 7.0). The filters were dried and processed for scintillation counting.
